Physician Scientist Incubator Track
About the Program
The Department of Pathology Physician Scientist Incubator Track (PSIT) is a formal career development program for those residents preparing for a career in which the majority of their professional time (generally, 70% or more) will be devoted to extramurally funded basic, translational or clinical research. Typical applicants have a strong research portfolio and have an MD, PhD.
Residency candidates interested in the PSIT are required to meet with department leadership (Chair or Vice Chair of Research) to discuss their candidacy during our interview season. If selected, a commitment will be made during residency recruitment season by the Chair, contingent upon matching.
Support
After completing their clinical residency training, these graduates of our training program are then eligible for up to three years of salary support for postdoctoral research as a faculty instructor with a minor clinical service component. During this three-year period, the Physician Scientist is expected to work closely with her or his mentor to launch a strong research program and apply for external support from the NIH, e.g., K08 award, and foundations. The clinical service component must be discussed with and approved by the appropriate service director and Chair. During the second year of clinical training, a meeting with the Chair should take place for planning.
Labs
The Department will assist residents in finding a suitable laboratory at Stanford for their mentored research training; the director of the laboratory may be a faculty member in the Department of Pathology or any other department in the University.
Indeed, Stanford University has an outstanding School of Engineering, which, together with the School of Medicine, has established a Bioengineering Department. Stanford University also has outstanding Departments of Biology, Chemistry and Statistics in the School of Humanities and Sciences.
In addition, Stanford CHEM-H is building bridges across the postdoctoral scholar community in chemistry, engineering, and medicine to encourage the execution of innovative research aimed at addressing challenges in human health from a multi-disciplinary perspective.
Physician Scientist Pathway Alumni
Tong Wang, MD, PhD
Instructor of Pathology, Stanford University
Research Focus and Awards
Chemical Biology, Epigenetics, Deep Learning
Education
Professional Education
MD, Perelman School of Medicine at the University of Pennsylvania, 2023
PhD, Perelman School of Medicine at the University of Pennsylvania, Biochemistry and Molecular Biophysics, 2021
Residency
Clinical Pathology, Physician Scientist Pathway, Stanford University School of Medicine, 2026
Fellowship
none
Publications
Sensitive, direct detection of non-coding off-target base editor unwinding and editing in primary cells, bioRxiv 2025 Wang, T.; Jessa, S.; Marinov, G. K.; Klemm, S.; Kundaje, A.; Greenleaf, W. J. https://doi.org/10.1101/2025.09.25.678665.
Application of Diagnostic Stewardship to Fungal PCR: Low Yield of Follow-up Testing on Plasma and BAL After a Negative Result. Clinical Infectious Diseases Wang, T.*; Park, B.*; Anderson, G.; Shaller, B.; Budvytiene, I.; Banaei, N. , 2024. 79 (4), 944-952. https://doi.org/10.1093/cid/ciae382.
Direct enzymatic sequencing of 5-methylcytosine at single base resolution. Nature Chemical Biology 2023. Wang, T.; Fowler, J. M.; Liu, L.; Loo, C. E.; Luo, M.; Schutsky, E. K.; Berríos, K. N.; DeNizio, J. E.; Dvorak, A.; Downey, N.; Montermoso, S.; Pingul, B.; Nasrallah, M.; Gosal, W.; Wu, H.; Kohli, R. M. 19, 1004–1012.* https://doi.org/10.1038/s41589-023-01318-1.
Discovery of an Unnatural DNA Modification Derived from a Natural Secondary Metabolite. Cell Chemical Biology. 2021 Wang, T and Kohli, R. M., 28, 1-8. https://doi.org/10.1016/j.chembiol.2020.09.006.
For more information and complete publication list, please visit:
Google Scholar
CAP Profile
PubMed
